Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.

Leber congenital amaurosis (LCA) is one of the most severe forms of inherited retinal degeneration and can be caused by mutations in at least 15 different genes. To clarify the proteomic differences in LCA eyes, a cohort of retinal degeneration 12 (rd12) mice, an LCA2 model caused by a mutation in t...

Full description

Bibliographic Details
Main Authors: Qinxiang Zheng, Yueping Ren, Radouil Tzekov, Yuanping Zhang, Bo Chen, Jiangping Hou, Chunhui Zhao, Jiali Zhu, Ying Zhang, Xufeng Dai, Shan Ma, Jia Li, Jijing Pang, Jia Qu, Wensheng Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3432120?pdf=render
_version_ 1828919861730869248
author Qinxiang Zheng
Yueping Ren
Radouil Tzekov
Yuanping Zhang
Bo Chen
Jiangping Hou
Chunhui Zhao
Jiali Zhu
Ying Zhang
Xufeng Dai
Shan Ma
Jia Li
Jijing Pang
Jia Qu
Wensheng Li
author_facet Qinxiang Zheng
Yueping Ren
Radouil Tzekov
Yuanping Zhang
Bo Chen
Jiangping Hou
Chunhui Zhao
Jiali Zhu
Ying Zhang
Xufeng Dai
Shan Ma
Jia Li
Jijing Pang
Jia Qu
Wensheng Li
author_sort Qinxiang Zheng
collection DOAJ
description Leber congenital amaurosis (LCA) is one of the most severe forms of inherited retinal degeneration and can be caused by mutations in at least 15 different genes. To clarify the proteomic differences in LCA eyes, a cohort of retinal degeneration 12 (rd12) mice, an LCA2 model caused by a mutation in the RPE65 gene, were injected subretinally with an AAV vector (scAAV5-smCBA-hRPE65) in one eye, while the contralateral eye served as a control. Proteomics were compared between untreated rd12 and normal control retinas on P14 and P21, and among treated and untreated rd12 retinas and control retinas on P42. Gene therapy in rd12 mice restored retinal function in treated eyes, which was demonstrated by electroretinography (ERG). Proteomic analysis successfully identified 39 proteins expressed differently among the 3 groups. The expression of 3 proteins involved in regulation of apoptosis and neuroptotection (alpha A crystallin, heat shock protein 70 and peroxiredoxin 6) were investigated further. Immunofluorescence, Western blot and real-time PCR confirmed the quantitative changes in their expression. Furthermore, cell culture studies suggested that peroxiredoxin 6 could act in an antioxidant role in rd12 mice. Our findings support the feasibility of gene therapy in LCA2 patients and support a role for alpha A crystallin, heat shock protein 70 and peroxiredoxin 6 in the pathogenetic mechanisms involved in LCA2 disease process.
first_indexed 2024-12-13T21:35:00Z
format Article
id doaj.art-46865d8a1dc1435f921b3939c729579a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T21:35:00Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-46865d8a1dc1435f921b3939c729579a2022-12-21T23:30:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4485510.1371/journal.pone.0044855Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.Qinxiang ZhengYueping RenRadouil TzekovYuanping ZhangBo ChenJiangping HouChunhui ZhaoJiali ZhuYing ZhangXufeng DaiShan MaJia LiJijing PangJia QuWensheng LiLeber congenital amaurosis (LCA) is one of the most severe forms of inherited retinal degeneration and can be caused by mutations in at least 15 different genes. To clarify the proteomic differences in LCA eyes, a cohort of retinal degeneration 12 (rd12) mice, an LCA2 model caused by a mutation in the RPE65 gene, were injected subretinally with an AAV vector (scAAV5-smCBA-hRPE65) in one eye, while the contralateral eye served as a control. Proteomics were compared between untreated rd12 and normal control retinas on P14 and P21, and among treated and untreated rd12 retinas and control retinas on P42. Gene therapy in rd12 mice restored retinal function in treated eyes, which was demonstrated by electroretinography (ERG). Proteomic analysis successfully identified 39 proteins expressed differently among the 3 groups. The expression of 3 proteins involved in regulation of apoptosis and neuroptotection (alpha A crystallin, heat shock protein 70 and peroxiredoxin 6) were investigated further. Immunofluorescence, Western blot and real-time PCR confirmed the quantitative changes in their expression. Furthermore, cell culture studies suggested that peroxiredoxin 6 could act in an antioxidant role in rd12 mice. Our findings support the feasibility of gene therapy in LCA2 patients and support a role for alpha A crystallin, heat shock protein 70 and peroxiredoxin 6 in the pathogenetic mechanisms involved in LCA2 disease process.http://europepmc.org/articles/PMC3432120?pdf=render
spellingShingle Qinxiang Zheng
Yueping Ren
Radouil Tzekov
Yuanping Zhang
Bo Chen
Jiangping Hou
Chunhui Zhao
Jiali Zhu
Ying Zhang
Xufeng Dai
Shan Ma
Jia Li
Jijing Pang
Jia Qu
Wensheng Li
Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.
PLoS ONE
title Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.
title_full Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.
title_fullStr Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.
title_full_unstemmed Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.
title_short Differential proteomics and functional research following gene therapy in a mouse model of Leber congenital amaurosis.
title_sort differential proteomics and functional research following gene therapy in a mouse model of leber congenital amaurosis
url http://europepmc.org/articles/PMC3432120?pdf=render
work_keys_str_mv AT qinxiangzheng differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT yuepingren differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT radouiltzekov differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT yuanpingzhang differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT bochen differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT jiangpinghou differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT chunhuizhao differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT jializhu differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT yingzhang differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT xufengdai differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT shanma differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT jiali differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT jijingpang differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT jiaqu differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis
AT wenshengli differentialproteomicsandfunctionalresearchfollowinggenetherapyinamousemodeloflebercongenitalamaurosis